title: Cancer Research Campaign operation manual for control recommendations for products derived from recombinant DNA technology prepared for investigational administration to patients with cancer in phase I trials.
authors.affiliation: University Department of Clinical Oncology, Royal Free Hospital School of Medicine, London, U.K.
authors.forename: R H
authors.initials: RH
authors.lastname: Begent
authors.forename: K A
authors.initials: KA
authors.lastname: Chester
authors.forename: T
authors.initials: T
authors.lastname: Connors
authors.forename: D
authors.initials: D
authors.lastname: Crowther
authors.forename: B
authors.initials: B
authors.lastname: Fox
authors.forename: E
authors.initials: E
authors.lastname: Griffiths
authors.forename: T A
authors.initials: TA
authors.lastname: Hince
authors.forename: J A
authors.initials: JA
authors.lastname: Ledermann
authors.forename: J G
authors.initials: JG
authors.lastname: McVie
authors.forename: P
authors.initials: P
authors.lastname: Minor
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017321:Clinical Trials, Phase I as Topic; D003257:Consumer Product Safety; D004274:DNA, Recombinant; D004348:Drug Labeling; D006801:Humans; D011994:Recombinant Proteins / Q000302:isolation & purification / Q000627:therapeutic use*; D011995:Recombination, Genetic
chemical_list: D000970:Antineoplastic Agents; D004274:DNA, Recombinant; D011994:Recombinant Proteins